| |
| |
|
| Insider
Information: |
Adelman Burt A |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
12,769 |
|
|
Indirect Shares
|
436,335 |
|
|
| Direct
Value |
$2,957,045 |
|
|
|
Indirect Value
|
$1,854,724 |
|
|
| Total
Shares |
449,104 |
|
|
| Total
Value |
$4,811,769 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
EVP, Portfolio Strategy |
2007-10-15 |
12,769 |
2007-10-15 |
8,009 |
Premium* |
|
|
Verve Therapeutics, Inc. |
VERV |
Director |
2021-12-02 |
0 |
2022-05-12 |
428,326 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
EVP, Development |
• – – |
2003-11-12 |
4 |
A |
$0.00 |
$0 |
D/D |
269 |
269 |
|
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Development |
• – – |
2005-06-28 |
4 |
AS |
$33.89 |
$10,167 |
D/D |
(300) |
18,000 |
|
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Portfolio Strategy |
• – – |
2007-05-30 |
5 |
GD |
$0.00 |
$0 |
I/I |
638 |
0 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Portfolio Strategy |
• – – |
2004-05-28 |
5 |
GD |
$0.00 |
$0 |
I/I |
674 |
7,335 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Portfolio Strategy |
• – – |
2005-06-14 |
5 |
GD |
$0.00 |
$0 |
I/I |
1,113 |
6,222 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
Director |
– • – |
2022-03-15 |
4 |
B |
$21.38 |
$85,535 |
I/I |
4,000 |
8,700 |
2.1 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Development |
• – – |
2007-03-14 |
4 |
D |
$44.11 |
$201,627 |
D/D |
(4,571) |
19,403 |
0 |
- |
|
| VERV |
Verve Therapeutics, Inc. |
Director |
– • – |
2021-12-02 |
4 |
B |
$31.34 |
$147,304 |
I/I |
4,700 |
4,700 |
2.1 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Development |
• – – |
2007-02-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,467 |
17,736 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Development |
• – – |
2007-02-06 |
4 |
D |
$48.94 |
$273,868 |
D/D |
(5,596) |
12,140 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Development |
• – – |
2007-03-20 |
4 |
AS |
$44.48 |
$295,073 |
D/D |
(6,634) |
12,769 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Development |
• – – |
2003-11-12 |
4 |
A |
$0.00 |
$0 |
I/I |
8,009 |
8,009 |
|
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP, Development |
• – – |
2003-12-04 |
4 |
AS |
$38.38 |
$331,028 |
D/D |
(8,625) |
269 |
|
- |
|
| BIIB |
Biogen Idec Inc |
Executive VP, Development |
• – – |
2003-12-04 |
4 |
OE |
$7.31 |
$63,049 |
D/D |
8,625 |
8,894 |
|
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Portfolio Strategy |
• – – |
2007-08-27 |
4 |
OE |
$43.50 |
$380,625 |
D/D |
8,750 |
21,519 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Portfolio Strategy |
• – – |
2007-08-27 |
4 |
AS |
$63.50 |
$555,625 |
D/D |
(8,750) |
12,769 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Development |
• – – |
2004-05-05 |
4 |
OE |
$12.91 |
$129,100 |
D/D |
10,000 |
60,300 |
|
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Development |
• – – |
2004-05-05 |
4 |
S |
$58.26 |
$582,804 |
D/D |
(10,000) |
59,000 |
|
- |
|
| VERV |
Verve Therapeutics, Inc. |
Director |
– • – |
2022-05-12 |
4 |
B |
$12.15 |
$121,526 |
I/I |
10,000 |
18,700 |
2.1 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Development |
• – – |
2005-09-28 |
4 |
AS |
$38.51 |
$394,444 |
D/D |
(10,200) |
7,800 |
|
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Portfolio Strategy |
• – – |
2007-07-03 |
4 |
AS |
$54.24 |
$554,604 |
D/D |
(10,225) |
12,769 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Portfolio Strategy |
• – – |
2007-07-03 |
4 |
OE |
$44.24 |
$452,354 |
D/D |
10,225 |
22,994 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Development |
• – – |
2005-09-28 |
4 |
AS |
$37.82 |
$394,881 |
D/D |
(10,300) |
20,500 |
|
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Development |
• – – |
2007-03-14 |
4 |
A |
$0.00 |
$0 |
D/D |
11,205 |
23,974 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP, Development |
• – – |
2007-02-13 |
4 |
AS |
$49.22 |
$584,243 |
D/D |
(11,871) |
12,769 |
0 |
- |
|
62 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
